Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diversity, equity, and access in psychedelic medicine
Monnica T. Williams, Beatriz Caiuby Labate
Journal of Psychedelic Studies (2019) Vol. 4, Iss. 1, pp. 1-3
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
Hannes Kettner, Fernando Rosas, Christopher Timmermann, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 152
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
Jacob S. Aday, Boris D. Heifets, Steven D. Pratscher, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1989-2010
Open Access | Times Cited: 148
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 144
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 124
Ethical and legal issues in psychedelic harm reduction and integration therapy
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 83
The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics
Aviad Hadar, Jonathan David, Nadav Shalit, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 1-10
Closed Access | Times Cited: 57
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability
Gregory Barber, Charles B. Nemeroff, Steven Siegel
American Journal of Psychiatry (2022) Vol. 179, Iss. 12, pp. 892-896
Closed Access | Times Cited: 45
The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision
Darron T. Smith, Sonya C. Faber, NiCole T. Buchanan, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 44
Research abuses against people of colour and other vulnerable groups in early psychedelic research
Dana Strauss, Sara de la Salle, Jordan Sloshower, et al.
Journal of Medical Ethics (2021) Vol. 48, Iss. 10, pp. 728-737
Closed Access | Times Cited: 46
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
Jacob S. Aday, Brian S. Barnett, Dan Grossman, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 150-165
Closed Access | Times Cited: 22
Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis
Caroline Peacock, Jennifer S. Mascaro, Erin Brauer, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296071-e0296071
Open Access | Times Cited: 6
Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists
Monnica T. Williams, Sara Reed, Jamilah R. George
Journal of Psychedelic Studies (2020) Vol. 4, Iss. 3, pp. 125-138
Open Access | Times Cited: 45
The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns
C. Bree Johnston, Maria Mangini, Charles S. Grob, et al.
American Journal of Geriatric Psychiatry (2022) Vol. 31, Iss. 1, pp. 44-53
Closed Access | Times Cited: 21
Manifest your desires: Psychedelics and the self-help industry
Patric Plesa, Rotem Petranker
International Journal of Drug Policy (2022) Vol. 105, pp. 103704-103704
Open Access | Times Cited: 20
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial
Terence H. W. Ching, Monnica T. Williams, Julie B. Wang, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 974-986
Closed Access | Times Cited: 20
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use
Daniel J. Kruger, Janice K. Albrecht, Jacob S. Aday, et al.
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
Social Worker Attitudes towards Psychedelics
Eva Nowakowski-Sims, Joshua Holzworth
Clinical Social Work Journal (2025)
Open Access
Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America
Terence H. W. Ching, Alan K. Davis, Yitong Xin, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 19-29
Closed Access | Times Cited: 17
Addiction specialists' attitudes toward psychedelics: A National Survey
Amanda Kim, Joji Suzuki
American Journal on Addictions (2023) Vol. 32, Iss. 6, pp. 606-609
Closed Access | Times Cited: 9
Leveraging meditation research for the study of psychedelic-related adverse effects
Roman Palitsky, Nicholas K. Canby, Nicholas T. Van Dam, et al.
International Review of Psychiatry (2024), pp. 1-15
Closed Access | Times Cited: 3
Beating pain with psychedelics: Matter over mind?
Igor Elman, Amanda C. Pustilnik, David Borsook
Neuroscience & Biobehavioral Reviews (2021) Vol. 134, pp. 104482-104482
Closed Access | Times Cited: 21
Entheogens and psychedelics in Canada: Proposal for a new paradigm.
Jessica Rochester, Anne Vallely, Paul Grof, et al.
Canadian Psychology/Psychologie canadienne (2021) Vol. 63, Iss. 3, pp. 413-430
Closed Access | Times Cited: 18
Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework
Kerri Rea, Bruce Wallace
International Journal of Drug Policy (2021) Vol. 98, pp. 103429-103429
Open Access | Times Cited: 18
Ensuring the psychedelic renaissance and radical healing reach the Black community: Commentary on Culture and Psychedelic Psychotherapy
NiCole T. Buchanan
Journal of Psychedelic Studies (2020) Vol. 4, Iss. 3, pp. 142-145
Open Access | Times Cited: 20
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Elena Argento, M. Eugenia Socías, Kanna Hayashi, et al.
International Journal of Drug Policy (2021) Vol. 100, pp. 103518-103518
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top